Collaboration. Navigation. Innovation.
Early results from clinical study
Southlake Regional Health Centre is the leading Canadian research site for the first phase of the Foresight ICE trial.
“The Foresight ICE has provided us a new option for guiding trans-septal puncture and I see potential in the 3D imaging that we will be able to take advantage of in several EP and structural cases.”Dr. Atul Verma
Director Arrhythmia Services
Southlake Regional Health Centre
Foresight™ ICE System Receives Clearance for New Features
Conavi is pleased to announce 510(k) clearance from the FDA for our Foresight ICE System expanded feature set. The enhancements include Color Doppler, Pulsed-Wave Doppler, 2D and 3D measurements, and ECG-gated 3D image acquisition.
Foresight ICE System™
Our Foresight ICE System™ gives users new features: Forward looking and 3D intracardiac ultrasound capabilities.
|Play Medical Animation|
Conavi Partners with Nova Scotia Health Authority and Government of Canada to Advance Patient Care
Conavi is pleased to announce that we are spearheading a collaborative effort to develop an imaging and tissue cutting probe for guided cardiovascular surgeries. The miniaturized probe leverages ultrasound technology for both imaging and precision cutting, allowing physicians to diagnose and treat serious conditions in a minimally invasive manner.
The Government of Canada is investing $2.6+ million over five years in the Nova Scotia Health Authority (NSHA) to develop the endoscope prototype. Throughout the development, Conavi will lend our medical and technological expertise to assist the NSHA in taking the solution from concept to creation. Upon creation, Conavi will commercialize the solution for cardiovascular surgical applications, allowing patients worldwide to benefit from improved clinical outcomes.
Fellow Toronto-based company Synaptive Medical will also assist in developing the solution and will likewise commercialize the solution for neurological applications.
Read more here.
DAIC Recognizes Conavi’s Innovation
Conavi is pleased to announce that our Foresight ICE System has been identified by Diagnostic and Interventional Cardiology (DAIC) as among the most innovative new technologies at the 2016 Transcatheter Cardiovascular Therapeutics (TCT) meeting in Washington, DC.
Reaching more than 25,000 healthcare professionals, DAIC is an award-winning cardiac technology publication. This year’s TCT allowed DAIC to become acquainted with Conavi’s Foresight ICE System—the first catheter-based system capable of providing both 2D and 3D ultrasound images of the cardiac anatomy around the circumference of the catheter’s tip.
Recognizing the clinical significance of our solution, DAIC singles out the Foresight ICE System in a video posted to its website. See the video here (we appear at the 3:18 mark).
Early Results from Study
The Foresight ICE System, developed out of Sunnybrook Research Institute, is the focus of Southlake Regional Health Centre’s first phase of the Foresight ICE study. This study is looking at the first clinical use and efficacy of 2D forward and 3D intracardiac echocardiography to guide trans-septal punctures during AF ablation procedures. Several patients have already had successful trans-septal puncture supported by the use of the Foresight ICE system.
It's clear that there's a need. We have a path to get there.Dr. Brian Courtney